{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:20:39Z","timestamp":1790839239798,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1735,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear. Methionine adenosyltransferase (MAT) is responsible for<\/jats:bold>\n                                 <jats:bold>\n                                    S\n                                 <\/jats:bold>\n                                 <jats:bold>-adenosylmethionine (SAMe) synthesis and MAT I and III are the products of the<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>gene. Deficient MAT I and III activities and SAMe content in the liver have been associated with NAFLD, but whether<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>is required for normal VLDL assembly remains unknown. We investigated the role of<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>on VLDL assembly in two metabolic contexts: in 3-month-old<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>-knockout mice (3-KO), with no signs of liver injury, and in 8-month-old<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>-knockout mice (8-KO), harboring nonalcoholic steatohepatitis. In 3-KO mouse liver, there is a potent effect of<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>deletion on lipid handling, decreasing mobilization of TG stores, TG secretion in VLDL and phosphatidylcholine synthesis via phosphatidylethanolamine<\/jats:bold>\n                                 <jats:bold>\n                                    N\n                                 <\/jats:bold>\n                                 <jats:bold>-methyltransferase.<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>deletion also increased VLDL\u2013 apolipoprotein B secretion, leading to small, lipid-poor VLDL particles. Administration of SAMe to 3-KO mice for 7 days recovered crucial altered processes in VLDL assembly and features of the secreted lipoproteins. The unfolded protein response was activated in 8-KO mouse liver, in which TG accumulated and the phosphatidylcholine-to-phosphatidylethanolamine ratio was reduced in the endoplasmic reticulum, whereas secretion of TG and apolipoprotein B in VLDL was increased and the VLDL physical characteristics resembled that in 3-KO mice.<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>deletion also altered plasma lipid homeostasis, with an increase in lipid transport in low-density lipoprotein subclasses and decrease in high-density lipoprotein subclasses.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>is required for normal VLDL assembly and plasma lipid homeostasis in mice. Impaired VLDL synthesis, mainly due to SAMe deficiency, contributes to NAFLD development in<\/jats:bold>\n                                 <jats:bold>\n                                    MAT1A\n                                 <\/jats:bold>\n                                 <jats:bold>-KO mice. (Hepatology 2011<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.24607","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T14:31:14Z","timestamp":1313073074000},"page":"1975-1986","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":88,"title":["Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice"],"prefix":"10.1097","volume":"54","author":[{"given":"Ainara","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Buqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Mart\u00ednez-U\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Aurrekoetxea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Menor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M.","family":"Mart\u00ednez-Chantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Aspichueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20250207","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-7-35","article-title":"Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.","volume":"7","author":"Sundaram","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"R2-11-20250207","doi-asserted-by":"crossref","first-page":"772780","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional verylowdensity lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.","volume":"50","author":"Fujita","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R3-11-20250207","doi-asserted-by":"crossref","first-page":"20382044","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.","volume":"49","author":"Minehira","year":"2008","journal-title":"J Lipid Res"},{"key":"R4-11-20250207","doi-asserted-by":"crossref","first-page":"679689","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R5-11-20250207","first-page":"2529","article-title":"Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.","volume":"17","author":"Fabbrini","year":"2009","journal-title":"Obesity Silver Spring"},{"key":"R6-11-20250207","doi-asserted-by":"crossref","first-page":"1639416402","DOI":"10.1016\/S0021-9258(18)49269-1","article-title":"Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.","volume":"262","author":"Borchardt","year":"1987","journal-title":"J Biol Chem"},{"key":"R7-11-20250207","doi-asserted-by":"crossref","first-page":"50805086","DOI":"10.1016\/S0021-9258(19)67758-6","article-title":"Oleate stimulates secretion of apolipoprotein Bcontaining lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.","volume":"266","author":"Dixon","year":"1991","journal-title":"J Biol Chem"},{"key":"R8-11-20250207","doi-asserted-by":"crossref","first-page":"18011808","DOI":"10.1016\/S0022-2275(20)39775-3","article-title":"Lipid balance in HepG2 cells: active synthesis and impaired mobilization.","volume":"35","author":"Gibbons","year":"1994","journal-title":"J Lipid Res"},{"key":"R9-11-20250207","first-page":"457462","article-title":"The lipolysisesterification cycle of hepatic triacylglycerol. Its role in the secretion of verylowdensity lipoprotein and its response to hormones and sulphonylureas.","volume":"284","author":"Wiggins","year":"1992","journal-title":"Biochem J"},{"key":"R10-11-20250207","doi-asserted-by":"crossref","first-page":"16851687","DOI":"10.1096\/fj.02-0728fje","article-title":"Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion.","volume":"17","author":"Gilham","year":"2003","journal-title":"FASEB J"},{"key":"R11-11-20250207","first-page":"125136","article-title":"Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from 2H6ethanol.","volume":"36","author":"Yang","year":"1996","journal-title":"J Lipid Res"},{"key":"R12-11-20250207","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoBlipoprotein assembly.","volume":"44","author":"Hussain","year":"2003","journal-title":"J Lipid Res"},{"key":"R13-11-20250207","doi-asserted-by":"crossref","first-page":"2043520442","DOI":"10.1074\/jbc.272.33.20435","article-title":"Cotranslational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein.","volume":"272","author":"Benoist","year":"1997","journal-title":"J Biol Chem"},{"key":"R14-11-20250207","doi-asserted-by":"crossref","first-page":"26742683","DOI":"10.1091\/mbc.e05-07-0659","article-title":"Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B.","volume":"17","author":"Ohsaki","year":"2006","journal-title":"Mol Biol Cell"},{"key":"R15-11-20250207","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.1002\/hep.22960","article-title":"Apolipoprotein B100 acts as a molecular link between lipidinduced endoplasmic reticulum stress and hepatic insulin resistance.","volume":"50","author":"Su","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R16-11-20250207","first-page":"10841088","article-title":"The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease.","volume":"9","author":"Gentile","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"R17-11-20250207","doi-asserted-by":"crossref","first-page":"316332","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipidinduced hepatic endoplasmic reticulum stress in rodents.","volume":"118","author":"Ota","year":"2008","journal-title":"J Clin Invest"},{"key":"R18-11-20250207","doi-asserted-by":"crossref","first-page":"29983004","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.","volume":"263","author":"Yao","year":"1988","journal-title":"J Biol Chem"},{"key":"R19-11-20250207","doi-asserted-by":"crossref","first-page":"4740247410","DOI":"10.1074\/jbc.M404027200","article-title":"Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins.","volume":"279","author":"Jacobs","year":"2004","journal-title":"J Biol Chem"},{"key":"R20-11-20250207","doi-asserted-by":"crossref","first-page":"4235842365","DOI":"10.1074\/jbc.M204542200","article-title":"An unexpected requirement for phosphatidylethanolamine Nmethyltransferase in the secretion of very low density lipoproteins.","volume":"277","author":"Noga","year":"2002","journal-title":"J Biol Chem"},{"key":"R21-11-20250207","doi-asserted-by":"crossref","first-page":"15301534","DOI":"10.1002\/hep.1840080610","article-title":"Specific loss of the highmolecularweight form of SadenosylLmethionine synthetase in human liver cirrhosis.","volume":"8","author":"Cabrero","year":"1988","journal-title":"HEPATOLOGY"},{"key":"R22-11-20250207","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1002\/hep.1840080113","article-title":"SadenosylLmethionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis.","volume":"8","author":"Duce","year":"1988","journal-title":"HEPATOLOGY"},{"key":"R23-11-20250207","doi-asserted-by":"crossref","first-page":"13061312","DOI":"10.1002\/hep.21650","article-title":"Role of SadenosylLmethionine in liver health and injury.","volume":"45","author":"Mato","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R24-11-20250207","doi-asserted-by":"crossref","first-page":"407415","DOI":"10.3109\/00365528909093067","article-title":"Effects of oral SadenosylLmethionine on hepatic glutathione in patients with liver disease.","volume":"24","author":"Vendemiale","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"R25-11-20250207","doi-asserted-by":"crossref","first-page":"55605565","DOI":"10.1073\/pnas.091016398","article-title":"Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.","volume":"98","author":"Lu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-11-20250207","doi-asserted-by":"crossref","first-page":"21522161","DOI":"10.1002\/hep.23530","article-title":"Sadenosylmethionine regulates dualspecificity mitogenactivated protein kinase phosphatase expression in mouse and human hepatocytes.","volume":"51","author":"Tomasi","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R27-11-20250207","doi-asserted-by":"crossref","first-page":"14821489","DOI":"10.1016\/S0022-2275(20)37430-7","article-title":"Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thinlayer chromatography and image analysis.","volume":"38","author":"Ruiz","year":"1997","journal-title":"J Lipid Res"},{"key":"R28-11-20250207","doi-asserted-by":"crossref","first-page":"911917","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification.","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"R29-11-20250207","doi-asserted-by":"crossref","first-page":"707717","DOI":"10.1152\/japplphysiol.00297.2009","article-title":"Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?","volume":"107","author":"Cano","year":"2009","journal-title":"J Appl Physiol"},{"key":"R30-11-20250207","doi-asserted-by":"crossref","first-page":"715725","DOI":"10.1016\/S0022-2275(20)32151-9","article-title":"Purification and properties of a cholesteryl ester hydrolase from rat liver microsomes.","volume":"40","author":"Cristobal","year":"1999","journal-title":"J Lipid Res"},{"key":"R31-11-20250207","first-page":"967974","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and reesterification by the glucocorticoid dexamethasone.","volume":"378","author":"Dolinsky","year":"2004","journal-title":"Biochem J"},{"key":"R32-11-20250207","first-page":"366374","article-title":"Phosphatidylethanolamine Nmethyltransferase from rat liver.","volume":"209","author":"Ridgway","year":"1992","journal-title":"Methods Enzymol"},{"key":"R35-11-20250207","doi-asserted-by":"crossref","first-page":"314321","DOI":"10.1016\/j.jhep.2006.08.024","article-title":"Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway.","volume":"46","author":"Kharbanda","year":"2007","journal-title":"J Hepatol"},{"key":"R36-11-20250207","doi-asserted-by":"crossref","first-page":"273293","DOI":"10.1146\/annurev.nutr.28.061807.155438","article-title":"Methionine metabolism and liver disease.","volume":"28","author":"Mato","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"R37-11-20250207","first-page":"159168","article-title":"Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion.","volume":"1258","author":"Fast","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"R38-11-20250207","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1042\/bst0320059","article-title":"Synthesis and function of hepatic verylowdensity lipoprotein.","volume":"32","author":"Gibbons","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"R39-11-20250207","first-page":"608617","article-title":"Evidence for LKB1AMPactivated protein kinaseendothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, Sadenosylmethionine, and nitric oxide in hepatocyte proliferation.","volume":"49","author":"VazquezChantada","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R40-11-20250207","doi-asserted-by":"crossref","first-page":"19251934","DOI":"10.1124\/mol.106.029421","article-title":"Stimulation of AMPactivated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.","volume":"70","author":"Rencurel","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R41-11-20250207","doi-asserted-by":"crossref","first-page":"10171026","DOI":"10.1194\/jlr.M500003-JLR200","article-title":"Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver.","volume":"46","author":"Aspichueta","year":"2005","journal-title":"J Lipid Res"},{"key":"R42-11-20250207","doi-asserted-by":"crossref","first-page":"11211129","DOI":"10.1038\/labinvest.2008.69","article-title":"Changes in Sadenosylmethionine and GSH homeostasis during endotoxemia in mice.","volume":"88","author":"Ko","year":"2008","journal-title":"Lab Invest"},{"key":"R43-11-20250207","doi-asserted-by":"crossref","first-page":"58625867","DOI":"10.1073\/pnas.0707460104","article-title":"Presecretory oxidation, aggregation, and autophagic destruction of apoproteinB: a pathway for latestage quality control.","volume":"105","author":"Pan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-11-20250207","doi-asserted-by":"crossref","first-page":"64536464","DOI":"10.1074\/jbc.M109.060467","article-title":"Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.","volume":"285","author":"Zhong","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24607","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201012000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:36:42Z","timestamp":1738946202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201012000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24607","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}